Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Teruhiro Utsugi"'
Autor:
Yuki Tanaka, Hiroshi Wada, Risa Goto, Toshihiro Osada, Keisuke Yamamura, Satoshi Fukaya, Atsushi Shimizu, Mitsuru Okubo, Kazuhisa Minamiguchi, Koichi Ikizawa, Eiji Sasaki, Teruhiro Utsugi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/badb391e12ce4c1c9c405c0223cc10d0
Publikováno v:
Allergology International, Vol 67, Iss 4, Pp 467-474 (2018)
Background: About one-third of the Japanese population suffers from Japanese cedar pollinosis, which is frequently accompanied by Japanese cypress pollinosis. Recently, a novel major Japanese cypress pollen allergen, Cha o 3, was discovered. However,
Externí odkaz:
https://doaj.org/article/98f2adde334b4d5c999f7e999ba4e363
Autor:
Rikio Suzuki, Shohei Kikuchi, Takeshi Harada, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Yasuhiro Yoshida, Morihiko Sagawa, Gullu Gorgun, Diana Cirstea, Francesca Cottini, Jana Jakubikova, Yu-Tzu Tai, Dharminder Chauhan, Paul G Richardson, Nikhil Munshi, Kiyoshi Ando, Teruhiro Utsugi, Teru Hideshima, Kenneth C Anderson
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0143847 (2015)
Heat shock protein (HSP)90 inhibitors have shown significant anti-tumor activities in preclinical settings in both solid and hematological tumors. We previously reported that the novel, orally available HSP90α/β inhibitor TAS-116 shows significant
Externí odkaz:
https://doaj.org/article/83ce039a22d7489a9099eed0350d4025
Autor:
Kenneth C. Anderson, Atsushi Iwama, Teruhiro Utsugi, Paul G. Richardson, Yu-Tzu Tai, Jiro Minami, Gullu Gorgun, Diana Cirstea, Jana Jakubikova, Francesca Cottini, Yasuhiro Yoshida, Shohei Kikuchi, Ola Rizq, Hiroto Ohguchi, Rikio Suzuki, Toshiyasu Shimomura, Teru Hideshima, Naoya Mimura
PDF file - 160K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5493f65879c18f6118b5fb1a7f9731f
https://doi.org/10.1158/0008-5472.22403631
https://doi.org/10.1158/0008-5472.22403631
Autor:
Kenneth C. Anderson, Atsushi Iwama, Teruhiro Utsugi, Paul G. Richardson, Yu-Tzu Tai, Jiro Minami, Gullu Gorgun, Diana Cirstea, Jana Jakubikova, Francesca Cottini, Yasuhiro Yoshida, Shohei Kikuchi, Ola Rizq, Hiroto Ohguchi, Rikio Suzuki, Toshiyasu Shimomura, Teru Hideshima, Naoya Mimura
PDF file - 648K, Figure S1. TAS-117 is a novel potent and selective inhibitor of Akt kinases. Figure S2. Basal expression of phosphorylated Akt and Akt in MM cell lines. Figure S3. TAS-117 inhibits neither MEK/ERK nor JAK2/STAT pathway. Figure S4. TA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec2e2f033e2c2d52a47684094e2581a
https://doi.org/10.1158/0008-5472.22403628
https://doi.org/10.1158/0008-5472.22403628
Autor:
Teruhiro Utsugi, Mitsuru Okubo, Atsushi Shimizu, Toshihiro Osada, Satoshi Fukaya, Keisuke Yamamura, Yuki Tanaka, Hiroshi Wada, Eiji Sasaki, Risa Goto, Koichi Ikizawa, Kazuhisa Minamiguchi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Cancer peptide vaccines are a promising cancer immunotherapy that can induce cancer-specific cytotoxic T lymphocytes (CTLs) in tumors. However, recent clinical trials of cancer vaccines have revealed that the efficacy of the vaccines is limited. Targ
Autor:
Teruhiro Utsugi, Fumihito Hosoi, Kenji F. Tanaka, Daichi Akasaka, Akihiro Saito, Ryusuke Kaneko, Naruto Noma, Yohei Yoshiga, Satoru Iguchi, Koichi Ikizawa, Yasunobu Arima
Publikováno v:
Poster Presentations.
Background Bone erosions and cartilage damages are a pathological hallmark of rheumatoid arthritis (RA) and are associated with poor functional outcome1. Aberrant activations of osteoclasts induced by receptor activator of nuclear factor κB ligand (
Publikováno v:
Allergology international : official journal of the Japanese Society of Allergology. 69(1)
Autor:
Seiji Miyahara, Takeshi Sagara, Kazutaka Miyadera, Hiroyuki Ueno, Takamasa Suzuki, Wakako Yano, Takuya Hoshino, Teruhiro Utsugi, Sayaka Tsukioka
Publikováno v:
Molecular Cancer Therapeutics. 18:A063-A063
Background: Ribonucleotide reductase (RNR) is an essential metabolic enzyme that catalyzes a rate-limiting step for de novo dNTP biosynthesis via converting ribonucleotides to deoxyribonucleotides. dNTPs are also supplied through nucleoside salvage p
Autor:
Kimihiro Ito, Fumio Nakagawa, Yayoi Fujioka, Hideki Nagase, Junji Uchida, Takeshi Sagara, Hiraku Itadani, Rumi Kawabata, Hiroki Irie, Shuichi Ohkubo, Kenichi Matsuo, Teruhiro Utsugi
Publikováno v:
Molecular Cancer Therapeutics. 18:A126-A126
Background: HER2-targeting antibodies (trastuzumab, pertuzumab) and an antibody-drug conjugate (trastuzumab emtansine: T-DM1) are available for the treatment of HER2 overexpressed breast cancer. TAS0728 is a small molecule, covalent-binding, selectiv